Pricing Log in Create free account

Affimed N.V. (AFMDQ) vs Eocene Ltd. (EOCN)

Affimed N.V. and Eocene Ltd. are both Biotechnology companies. Affimed N.V. and Eocene Ltd. are of similar size ($2.8M and $2.6M). Eocene Ltd. grew revenue faster over the last twelve months: 87.8% against −95.2%. Eocene Ltd. has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (−163.2% vs −13,558.8%). Across the 16 metrics below, Eocene Ltd. leads on 10 and Affimed N.V. on 6.

Valuation

Metric AFMDQ EOCN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.28 9.40
P/B n/m 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.26 0.63 0.66
EV/Sales (19.16) (3.06) 9.02
Earnings yield 0.00% (518.42%) (32.88%)
Free cash flow yield 0.00% (327.63%) (23.13%)

Profitability

Metric AFMDQ EOCN Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (7,858.63%) 0.00% 0.00%
Net margin (7,834.59%) 0.00% 0.00%
Free cash flow margin (8,603.91%) 0.00% 0.00%
Return on equity (148.64%) (68.21%) (51.96%)
Return on assets (86.68%) (55.03%) (46.06%)
Return on invested capital (13,558.83%) (163.19%) 0.00%

Growth

Metric AFMDQ EOCN Biotechnology median
Revenue growth (TTM) (95.23%) 87.83% 6.76%
EPS growth (last fiscal year) (21.75%) 70.42% 29.88%
Revenue growth, 5-year CAGR (20.40%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ EOCN Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 4.16 4.97
Net debt to EBITDA 0.58 1.31 1.01

Dividend

Metric AFMDQ EOCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AFMDQ EOCN Biotechnology median
Market cap 2.76m 2.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack